European Genome-phenome Archive (EGA)
The European Genome-phenome Archive (EGA) is a non-profit research infrastructure jointly operated by CRG and EMBL-EBI under ELIXIR, providing permanent archiving and controlled sharing of genetic, phenotypic, and clinical data for the global biomedical research community via a federated network of national nodes.
- Company typePrivate
- Founded-
- Headquarters—
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What European Genome-phenome Archive (EGA) does
The European Genome-phenome Archive (EGA) is a non-profit research data infrastructure operated jointly by the Centre for Genomic Regulation (CRG) in Barcelona, Spain, and the European Molecular Biology Laboratory – European Bioinformatics Institute (EMBL-EBI) in Hinxton, United Kingdom. It provides permanent archiving and controlled sharing of personally identifiable genetic, phenotypic, and clinical data generated for biomedical research projects and research-focused healthcare systems. EGA functions as an ELIXIR Core Data Resource within Europe's life-science infrastructure, serving the global biomedical research community under a community-led go-to-market model in which researchers voluntarily submit data through the Submitter Portal and request access through Data Access Committees (DACs).
The platform's core technology is a secure, permanent archive with controlled access, anchored by Crypt4gh encryption for file preparation and transfer, a Public Metadata API for discovery, a Submitter Portal API for programmatic ingestion, and the Federated EGA network of regional archive nodes (Canada, Finland, Norway, Poland, Portugal, Spain, Sweden) that allow national jurisdictions to retain local custody of sensitive data while preserving global discoverability. User-facing access tools include PyEGA3 (Python download client), FUSE Client (virtual filesystem mount for visualization), EGA QuickView (browser-based preview), and the DAC Portal for governance workflows. Integration with the GA4GH standards body and contribution to the Beacon Project extend interoperability into the wider federated genomics ecosystem.
EGA operates as a publicly funded research infrastructure with no commercial revenue; the service is free to submitters and approved data requesters, and operating support flows through ELIXIR and national research council mechanisms. Its ownership structure is the EGA Consortium, jointly controlled by CRG and EMBL-EBI, with each Federated EGA node managed locally under a jointly-controlled relationship with the central archive. The firm is not investable in the traditional PE/VC sense — it is a research utility with regulatory mandate and a long-term public funding horizon rather than a revenue-generating enterprise.
European Genome-phenome Archive (EGA) firmographics
Firmographics- Name
- European Genome-phenome Archive (EGA)
- Legal name
- EGA Consortium
- Website
- https://ega-archive.org
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- The European Genome-phenome Archive (EGA) is a non-profit research infrastructure jointly operated by CRG and EMBL-EBI under ELIXIR, providing permanent archiving and controlled sharing of genetic, phenotypic, and clinical data for the global biomedical research community via a federated network of national nodes.
- Ownership category
- akta.pro rank
European Genome-phenome Archive (EGA) industry classification
Industry- Product category
- Biomedical Research Data Archive
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Patient-Mediated Exchange & Personal Health Data Access (Blue Button, SMART on FHIR) (HLACABAN)
Keywords
European Genome-phenome Archive (EGA) business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Infrastructure, Technology or R&D, Operations
Revenue model
- Public Infrastructure Funding: EGA operates as a publicly funded research infrastructure, supported by European research funding mechanisms including ELIXIR infrastructure and national research councils. No commercial revenue is generated from data archiving or access.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
European Genome-phenome Archive (EGA) product offering
Product offeringCore offering
EGA is a public service for the permanent archiving and sharing of personally identifiable genetic, phenotypic, and clinical data generated for biomedical research projects or within research-focused healthcare systems. It operates a centralized archive with structured Data Access Committee (DAC) governance, federated regional nodes across Europe and Canada, and a suite of web portals and APIs (Submitter Portal, DAC Portal, Public Metadata API) plus download and visualization tools (PyEGA3, FUSE Client, EGA QuickView) protected by Crypt4gh encryption.
Product overview
The European Genome-phenome Archive (EGA) is a centralized service for permanent archiving and sharing of personally identifiable genetic, phenotypic, and clinical data for biomedical research. The platform consists of a web-based discovery interface with a Public Metadata API, a Submitter Portal and API for data deposition, a DAC Portal for managing data access permissions, and various download/visualization tools (PyEGA3, FUSE Client, EGA QuickView). Data is secured using Crypt4gh encryption. EGA operates as a federated network with regional nodes across Europe and Canada, connected through Federated EGA.
Differentiator
Problem solved
Functional benefit
Products and services
- Submitter Portal Web-based portal that allows researchers and institutions to submit sequencing and phenotype metadata to the EGA archive.
- Submitter Portal API Programmatic interface enabling automated submission of sequencing and phenotype metadata to the EGA via XML or direct integration.
- DAC Portal Dedicated web portal for Data Access Committees to review, manage, and approve data access requests on archived datasets.
- Public Metadata API Unauthenticated API that exposes metadata about studies, datasets, and Data Access Committees for discovery and search across the archive.
- PyEGA3 Python-based command-line client for downloading files from EGA, supporting authentication and batch downloads.
- FUSE Client File-system client that mounts EGA archive contents as a virtual drive for browsing and visualization of data.
- EGA QuickView Web-based visualization tool that lets users preview genomic data files in the archive without performing a full download.
- Crypt4gh Encryption standard and supporting tools used by submitters to secure genomic data files during preparation, upload, and storage at EGA.
- Federated EGA Network Distributed archive network with national/regional submission nodes in Canada, Finland, Norway, Poland, Portugal, Spain, and Sweden that host data locally while maintaining global discoverability through the central EGA catalogue.
Companies that use European Genome-phenome Archive (EGA)
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
European Genome-phenome Archive (EGA) technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
European Genome-phenome Archive (EGA) partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- ELIXIRcoreEGA is an integral part of the ELIXIR infrastructure, designated as an Elixir Core Data Resource. This partnership provides operational funding, governance framework, and strategic alignment with European life science data infrastructure initiatives.
- EMBL-EBI (European Bioinformatics Institute)coreEGA operates using EMBL-EBI's computational infrastructure for data storage, archival services, and global data distribution. EGA data is hosted on EMBL-EBI systems.
- CRG (Centre for Genomic Regulation)coreCRG in Barcelona is a core operational partner of the EGA Consortium, contributing technical expertise and infrastructure for archive operations.
- GA4GH (Global Alliance for Genomics and Health)coreEGA participates in GA4GH standards development and implementations for genomic data sharing, contributing to and adopting international standards for responsible data sharing.
- Federated EGA ConsortiumcoreNetwork of national Federated EGA nodes (Canada, Finland, Norway, Poland, Portugal, Spain, Sweden) enabling regional data storage while maintaining global discoverability through the central EGA infrastructure.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
European Genome-phenome Archive (EGA) competitors and assessment
Company assessmentDirect peers
- All of Us Research Program: NIH's million-person U.S. precision medicine cohort that archives genomic and health data with a controlled-access model. It is comparable to EGA in scope, governance approach (data access committees), and target audience of biomedical researchers, and represents a competing large-scale controlled-access genomic resource.
- Database of Genotypes and Phenotypes (dbGaP): NIH's controlled-access repository for genotype and phenotype data in the U.S. dbGaP is the most direct functional peer to EGA: both archive personally identifiable human genomic and phenotypic data with mediated access review, and many researchers submit data to one and request from the other.
- European Genome-phenome Archive (mirror at CRG): Note: same as subject company — the EGA itself is operated jointly by CRG and EMBL-EBI. Listed here only as a structural reference to highlight that the two principal institutions backing EGA also operate adjacent resources that shape its ecosystem.
Regional players
- The Cancer Genome Atlas (TCGA): A U.S. NCI/NHGRI program that generated and archived multi-omics cancer data accessible through controlled-access mechanisms. It is comparable to EGA in mediating controlled access to large-scale human genomic and phenotypic datasets, though it is U.S.-only and disease-specific.
Others
- Global Alliance for Genomics and Health (GA4GH): An international standards-setting alliance for genomic data sharing in which EGA is a participating member. It is comparable not as a competitor but as a peer institution shaping the interoperability, consent, and access frameworks that EGA implements in its platform.
- ELIXIR: The European research infrastructure consortium of which EGA is a Core Data Resource. It is comparable as the institutional umbrella under which EGA is funded, governed, and integrated with other life-science data resources across Europe.
- 1000 Genomes Project: An international research effort that produced one of the first large public catalogues of human genetic variation, with data archived and distributed through ENA and EBI infrastructure. It is comparable to EGA as a precedent-defining genomic data resource served through overlapping EMBL-EBI infrastructure.
Emerging players
- UK Biobank: A large-scale biomedical database and research resource containing genomic, phenotypic, and health data from 500,000+ UK participants. It is comparable to EGA in that it mediates controlled access to sensitive genomic data for approved researchers, though it is a single-population cohort rather than a multi-study archive.
Broad incumbents
- European Nucleotide Archive (ENA): Operated by EMBL-EBI alongside EGA, ENA is a comprehensive open-access archive for nucleotide sequencing data. It is comparable because it shares EMBL-EBI infrastructure with EGA and serves an overlapping research community, though ENA focuses on open raw sequence data while EGA handles controlled-access human data.
- Gene Expression Omnibus (GEO): NCBI's public repository for gene expression and other functional genomics datasets. While GEO is open-access and does not handle personally identifiable human data like EGA, it is comparable as a parallel NCBI/NIH data archive serving a similar researcher community with adjacent data types.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
European Genome-phenome Archive (EGA) social profiles
Digital presenceEuropean Genome-phenome Archive (EGA) financial estimates
Financial estimateRevenue estimate
Valuation estimate
European Genome-phenome Archive (EGA) leadership team
Management profileNumber of profiles
European Genome-phenome Archive (EGA) subsidiaries and ownership
Company hierarchySubsidiaries7 records
European Genome-phenome Archive (EGA) funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
European Genome-phenome Archive (EGA) M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about European Genome-phenome Archive (EGA)
What does European Genome-phenome Archive (EGA) do?
EGA is a public service for the permanent archiving and sharing of personally identifiable genetic, phenotypic, and clinical data generated for biomedical research projects or within research-focused healthcare systems. It operates a centralized archive with structured Data Access Committee (DAC) governance, federated regional nodes across Europe and Canada, and a suite of web portals and APIs (Submitter Portal, DAC Portal, Public Metadata API) plus download and visualization tools (PyEGA3, FUSE Client, EGA QuickView) protected by Crypt4gh encryption.
Is European Genome-phenome Archive (EGA) a public or private company?
European Genome-phenome Archive (EGA) is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was European Genome-phenome Archive (EGA) founded?
European Genome-phenome Archive (EGA) was founded in -1. It employs 1 to 10 people.
How does European Genome-phenome Archive (EGA) make money?
One revenue line is on record: public Infrastructure Funding.
Who are European Genome-phenome Archive (EGA)'s main competitors?
Direct peers on record are All of Us Research Program, Database of Genotypes and Phenotypes (dbGaP) and European Genome-phenome Archive (mirror at CRG). The Cancer Genome Atlas (TCGA) is listed as a regional player. Others are Global Alliance for Genomics and Health (GA4GH), ELIXIR and 1000 Genomes Project. UK Biobank is listed as an emerging player. Broad incumbents are European Nucleotide Archive (ENA) and Gene Expression Omnibus (GEO).
Does European Genome-phenome Archive (EGA) have an API?
Yes. EGA offers two main APIs: 1) Public Metadata API for discovering studies, datasets, and DACs metadata without authentication; 2) Submitter Portal API for programmatic submission of sequencing and phenotype data. The APIs enable automated access to archive contents and data submission workflows. Developer documentation is at ega-archive.org/discovery/metadata/public-metadata-api.
What industry is European Genome-phenome Archive (EGA) in?
European Genome-phenome Archive (EGA)'s product category is Biomedical Research Data Archive. Its primary akta.pro industry code is HLACABAN, Patient-Mediated Exchange & Personal Health Data Access (Blue Button, SMART on FHIR). Its NAICS code is 518210 and its SIC code is 7370.